Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000884980 | SCV001028393 | likely benign | Nemaline myopathy 2 | 2024-02-09 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000884980 | SCV001452175 | uncertain significance | Nemaline myopathy 2 | 2020-03-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004550028 | SCV004792017 | likely benign | NEB-related disorder | 2019-03-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |